United States: CMS Seeks To Lower Costs And Increase Competition With Step Therapy For Medicare Part B Drugs - Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Wednesday, 22 August 2018 () As a continuation of the recent drug pricing developments tied the Trump Administration's American Patients First Blueprint, beginning January 1, 2019
Wednesday, 22 August 2018 ()